Ramona Doyle
Equibles does not estimate personal net worth.
About Ramona Doyle
The proxy statement of Recursion Pharmaceuticals, Inc. reports total compensation of $1,207,406 for Ramona Doyle in fiscal 2022, including a base salary of $167,933. Disclosed compensation is on record for 3 fiscal years.
Affiliation history
-
Recursion Pharmaceuticals, Inc. (RXRX)
Proxy statement
Start not stated–2022-04-28
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief Medical Officer | $167,933 | $1,207,406 |
| 2021 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief Medical Officer | $440,282 | $607,456 |
| 2020 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief Medical Officer | $3,666 | $1,137,997 |
Recent activity
No call appearances or filed executive changes recorded yet.